Skip to main content

What the FDA labels say about taking them together

Fosamprenavir and trazodone

Fosamprenavir's FDA label of September 15, 2023 names trazodone in its drug interactions section; the trazodone labels PlainMeds reads (2) do not name fosamprenavir. The fosamprenavir label: “Any paroxetine dose adjustment should be guided by clinical effect.”

Check it at the source: the fosamprenavir FDA label on DailyMed (effective September 15, 2023, Mylan Pharmaceuticals Inc.); the trazodone FDA label on DailyMed (effective January 22, 2026, Zydus Pharmaceuticals USA Inc.).

What does the fosamprenavir label say about trazodone?

Fosamprenavir label, drug interactions

Concomitant Drug Class/Drug Name: Antidepressant: Paroxetine, trazodone; Effect on Concentration of Amprenavir or Concomitant Drug: ↓ Paroxetine; Clinical Comment: Any paroxetine dose adjustment should be guided by clinical effect (tolerability and efficacy).

Source: FDA drug label (Fosamprenavir Calcium), Mylan Pharmaceuticals Inc., effective September 15, 2023 (SPL set 3a1424d8-844c-4e24-9ebd-b2c2b61b61a3), via openFDA; the full label on DailyMed

What does the trazodone label say about fosamprenavir?

Trazodone's label (effective January 22, 2026) and its 1 other brand-application label do not name fosamprenavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Trazodone Hydrochloride), Zydus Pharmaceuticals USA Inc., effective January 22, 2026 (SPL set 704aebf9-2fff-4ef3-8323-9ff0d7f0ffd9), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

2Fosamprenavir generic labelers
38Trazodone generic labelers
FosamprenavirTrazodone
Labeled forHIVDepression
Boxed warningNoYes
Pharmacy cost (NADAC)n/a$0.0307 per tablet 50 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?